Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells

Author(s):
Lelieveldt, L.P.W.M.; Kristyanto, H.; Pruijn, G.J.M.; Scherer, H.U. (0000-0002-5700-5617); Toes, R.E.M. (0000-0002-9618-6414); Bonger, K.M.
Published
2018
Publication type
Article / Letter to editor
Rheumatoid arthritispeptidylcitrullineanticitrullinated protein antibodiesB cell targetingantigen silencing and activation
Date issued
2018-12-31
Language
English
Is part of
Molecular Pharmaceutics (2018), Vol. 15, no. 12, p. 5565-5573
hdl
1887/78043
doi
10.1021/acs.molpharmaceut.8b00741
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282105/